Search | Page 5 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. REVERSE 1 INCB 18424-271

    ... of corticosteroids is achieved. • Evidence of myeloid engraftment (eg, absolute neutrophil count ≥ 1.0 × 10^9/L for 3 ... is allowed. Evidence of platelet engraftment (ie, platelets ≥ 20 × 10^9/L) ...

    Clinical Trial last updated 12/14/2016 - 11:24am.

  2. TBI Dose De-escalation for Fanconi Anemia

    ... mofetil (MMF) through day +30 or for 7 days after engraftment , whichever day is later, if no acute graft-versus-host ... beginning on day -3 through day +30 or for 7 days after engraftment, whichever day is later, if no acute graft-versus-host disease ...

    Clinical Trial last updated 04/28/2016 - 9:06am.

  3. Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure

    ... results thus far. Our long term leukocyte engraftment rate is 85-90% with the same disease-free survival. None of the ... limitation is the significant delay in donor red cell engraftment in one recipient who had pre-existing allo-antibody to donor red ...

    Clinical Trial last updated 04/28/2016 - 9:09am.

  4. Cord Blood Transplant

    ... early skepticism in adults because of concerns about the engraftment potential of the relatively limited number of stem cells. The ... recipients from the NYBC revealed a cumulative rate of engraftment of 81% by day 42 for PMNs. and 85% by day 180 for platelets. ...

    Clinical Trial last updated 04/27/2016 - 9:59am.

  5. Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia

    ... regimen-related toxicity while maintaining better engraftment , this study is to evaluate the effectiveness and safety of ... survival probability at 3 months, 6 months and 1 year. Engraftment at 3 months, 6 months and 1 year Incidence of graft versus host ...

    Clinical Trial last updated 04/08/2016 - 11:25pm.

  6. CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease

    ... the time to neutrophil and platelet engraftment , to determine the time to immune reconstitution (including ...

    Clinical Trial last updated 06/13/2016 - 2:06pm.

  7. Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases

    ... stem cell transplant to facilitate engraftment and the safety of AP1903 on day 7 to prevent GVHD. ...

    Clinical Trial last updated 06/13/2016 - 1:54pm.

  8. New York Blood Center National Cord Blood Program

    ... to assess cord blood myeloid and platelet engraftment , transplant related mortality, overall survival, graft vs. host ...

    Clinical Trial last updated 06/13/2016 - 1:43pm.

  9. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

    ... B cell depletion to determine efficacy as determined by engraftment and GVHD, and one year leukemia free survival. ...

    Clinical Trial last updated 06/06/2016 - 3:10pm.

  10. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

    ... B cell depletion to determine efficacy as determined by engraftment and GVHD, and one year leukemia free survival. ...

    Clinical Trial last updated 06/03/2016 - 2:45pm.